Home > Income Statement > GENPHARMASEC

GENPHARMASEC
Revenue

    Back to Income Statement
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Revenue History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹26 Cr₹27 Cr₹21 Cr₹17 Cr₹0.38 Cr

What is the latest Revenue of GENPHARMASEC ?

The latest Revenue ratio of GENPHARMASEC is ₹26 Cr based on Mar2023 Standalone results.
Year Revenue
Mar2023₹26 Cr
Mar2022₹27 Cr
Mar2021₹21 Cr
Mar2020₹17 Cr
Mar2019₹0.38 Cr

How is Revenue of GENPHARMASEC Trending?

Years Revenue % Change
Mar2023 ₹26 Cr
-6.61
Mar2022 ₹27 Cr
28.22
Mar2021 ₹21 Cr
29.13
Mar2020 ₹17 Cr
4,300.27
Mar2019 ₹0.38 Cr -

Compare Revenue of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹121.8 Cr -0.5% -1.4% 20.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹4,996.8 Cr -0.8% 18.4% 79.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,336.2 Cr 1.5% 3% 21.7% Stock Analytics
KIRI INDUSTRIES ₹1,895.8 Cr -3.2% 20.6% 23.5% Stock Analytics
BODAL CHEMICALS ₹978.1 Cr -2.8% 6.1% 12.2% Stock Analytics
BHAGERIA INDUSTRIES ₹745.2 Cr -4.6% 17.6% 33.2% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-0.5%

-1.4%

20.3%

SENSEX

1%

2.2%

23.7%


You may also like the below Video Courses